Daniel Meirelles Barbalho

ORCID: 0000-0002-1788-6720
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Implant and Reconstruction
  • Reconstructive Surgery and Microvascular Techniques
  • Breast Cancer Treatment Studies
  • DNA Repair Mechanisms
  • BRCA gene mutations in cancer
  • Genomic variations and chromosomal abnormalities
  • Advanced Radiotherapy Techniques
  • Cancer Diagnosis and Treatment
  • Dermatological and COVID-19 studies
  • Antimicrobial Resistance in Staphylococcus
  • Cancer Genomics and Diagnostics
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Advances in Oncology and Radiotherapy
  • Sarcoidosis and Beryllium Toxicity Research
  • Streptococcal Infections and Treatments
  • Medical Imaging Techniques and Applications
  • Mesenchymal stem cell research
  • Digital Imaging in Medicine
  • Autoimmune and Inflammatory Disorders
  • Nonmelanoma Skin Cancer Studies

Hospital Sírio-Libanês
2021-2024

Hospital Universitário de Brasília
2018

European Institute of Oncology
2011-2014

Autologous fat graft to the breast is a useful tool correct defects after conservative treatment (BCT). Although this procedure gains popularity, little known about interaction between and prior oncological environment. Evidences of safety in healthy post-mastectomy reconstruction exist. However, there paucity data among patients who underwent BCT which are hypothetically under higher risk local recurrence (LR). Fifty-nine patients, with BCT, 75 autologous procedures using Coleman's...

10.1111/tbj.12225 article EN The Breast Journal 2014-01-23
Giacomo Montagna Alison Laws Massimo Ferrucci Mary Mrdutt Susie X. Sun and 95 more Süleyman Bademler Hakan Balbaloğlu Nora Balint‐Lahat Malgorzata Banys-Paluchowski Andrea V. Barrio John R. Benson Nuran Beşe Judy C. Boughey Marissa K. Boyle Emilia J. Diego Claire Eden Ruth Eller Maite Goldschmidt Callie Hlavin Martin Heidinger Justyna Jelinska Güldeniz Karadeniz Çakmak Susan B. Kesmodel Tari A. King Henry M. Kuerer Julie M Loesch Francesco Milardi Dawid Murawa Tracy‐Ann Moo Tehillah S. Menes Daniele Passeri Jessica Pastoriza Andraž Perhavec Nina Pislar Natália Polidorio Avina Rami Jai Min Ryu Alexandra Schulz Varadan Sevilimedu Mustafa Ümit Uğurlu Cihan Uras Annemiek K. E. van Hemert Stephanie M. Wong Tae-Kyung Yoo Jennifer Q. Zhang Hasan Karanlık Neslihan Cabıoğlu Marie-Jeanne T. F. D. Vrancken Peeters Monica Morrow William P. Weber Sung Gwe Ahn Mariacarla Andreozzi Daniel Meirelles Barbalho J.-F. Boileau Edi Brogi Flávia Vidal Cabero Daniela Cocco Fabio Corsi Angelena Crown Eelco de Bree M. Vernet-Tomás Christine Deutschmann Nina Ditsch Emanuela Esposito Oluwadamilola M. Fayanju Franziska Fick Florian Fitzal Meghan R. Flanagan Damiano Gentile Oreste ­Gentilini Anne Grabenstetter Mehmet Ali Gülçelik Jörg Heil Johannes Holtschmidt Natalia Krawczyk Thorsten Kühn Sherko Kümmel Cornelia Leo Mahmut Muslumanoglu Valentina Nekljudova Lisa A. Newman Melissa Pilewskie Nikiforita Poulakaki Fabian Riedel Nicola Rocco Freya Schnabel Christopher J. Schwartz Emily Siegel Colin Simonson Christian F. Singer Leonardo Ribeiro Soares Ekaterini Christina Tampaki Athanasios Tampakis Marios Konstantinos Tasoulis Christoph Tausch Cícero Úrban Astrid Botty van den Bruele Glenn Vergauwen Denise Vorburger Fredrik Wärnberg

The nodal burden of patients with residual isolated tumor cells (ITCs) in the sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC) (ypN0i+) is unknown, and axillary management not standardized. We investigated rates additional positive (LNs) at node dissection (ALND) oncologic outcomes ypN0i+ treated without ALND.

10.1200/jco.24.01052 article EN Journal of Clinical Oncology 2024-11-07

Brazil is the largest country in South America and most genetically heterogeneous. The aim of present study was to determine prevalence germline pathogenic variants (PVs) Brazilian patients with breast cancer (BC) who underwent genetic counseling testing at a tertiary Oncology Center. We performed retrospective analysis medical records BC referred between August 2017 2019. A total 224 unrelated were included this study. Premenopausal women represented 68.7% cohort. median age diagnosis 45...

10.1371/journal.pone.0247363 article EN cc-by PLoS ONE 2021-02-19

Fasciíte necrotizante é uma infecção agressiva que acomete o subcutâneo e fáscias superficiais por necrose, mais frequentemente encontrada em parede abdominal, períneo extremidades.Raros casos foram descritos na mama a literatura aponta amamentação procedimentos mamários prévios como fatores de riscos para essa condição.Apresentamos paciente no puerpério, 27 anos, apresentou fissura mamilo direito associada à evoluiu com local agressiva, necrose extensa parênquima mamário caracterizada...

10.29289/2594539420180000348 article PT Mastology 2018-06-01

Breast cancer patients with germline pathogenic variants may benefit from risk-reducing surgeries, intensive screening, and targeted therapies. There is a paucity of data regarding prevalence distribution in the Brazilian population. Our primary endpoint was description among breast who underwent next-generation sequencing (NGS) panel testing. Secondary assessment predictive factors positive test.We analyzed NGS results, personal, family history prospectively collected cohort August 2013 to...

10.3389/fonc.2021.743231 article EN cc-by Frontiers in Oncology 2022-01-28

Local treatment can be distressful to breast cancer patients. We aimed evaluate how different types of local impact the quality life

10.3389/fonc.2024.1465769 article EN cc-by Frontiers in Oncology 2024-10-18

Objective: Breast cancer is one of the leading causes in women worldwide. Local treatment can be distressful to patients. We aimed evaluate how different types local impact quality life breast Methodology: Breast-Q Satisfaction with Breasts scores were collected before surgery and 1 year post-operatively after a first oncologic surgery. Linear regression was used estimate conservation, use oncoplastic surgery, reconstruction, radiation therapy on scores. All analyses adjusted by age,...

10.29289/259453942024v34s1018 article EN Mastology 2024-01-01

reproductive history; women who gave last birth within 2 years prior to diagnosis were classified into Group A (n = 37), between 3 and 5 B 59), more than C 118), nulliparous N 247).Results: Parous with breast cancer significantly older women.There was no significant difference in clinical pathological characteristics parous women.Patients recent childbirth had advanced stage, larger tumour, node-positive disease, higher histological grade, PgR-negative HER2-positve disease compared the...

10.1016/s0960-9776(12)70057-7 article EN cc-by-nc-nd The Breast 2012-11-01
Coming Soon ...